semaglutide ads Novo Nordisk calls out dangers of compounded GLP-1s in new ad Weight loss Super Bowl ad
Description
Progressive overload is essential
According to a 2026 report from KFF, insurers are generally more likely to cover GLP-1 drugs prescribed for type 2 diabetes than those prescribed for obesity treatment
- Vial format for flexible use
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats
The change means it is a breach of section 43 of the Medicines Act 1981 to import and possess peptides that are prescription medicines
